Josh Brown, CEO of Ritholtz Wealth Management, made a pointed claim on CNBC’s Halftime Report this week about large-cap ...

Twelve months ago, drugmakers came roaring into 2025, fueled by a massive year of growth that peaked in the fourth quarter of ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...

On February 5, 2026, President Trump released another namesake initiative, this time aimed at prescription drug prices. The new program, TrumpRx, is advertised as delivering “the world’s lowest prices ...

AbbVie recently reported record 2025 results and outlined a stronger 2026 outlook, while advancing key immunology assets and completing the VOLITE skin quality aesthetics trial to bolster its ...

Good morning, everyone, and well, happy Friday, the 13th. And on a serious note, thanks for joining us for day 2 of our Piper's Virtual Immunology Symposium. So we're delighted to have AbbVie with us.

On Friday, 13 February 2026, AbbVie (NYSE:ABBV) presented its strategic vision at the Conference Piper Sandler Virtual Novel Targets in Immunology Symposium. The company showcased its innovative ...

[Audio Gap] Biotech Summit 2026. My name is Yatin Suneja. I'm joined here with my colleague, Delma Caiati. We will be moderating the next discussion with Dianthus Therapeutics. From the company, we ...